EUVIMEDOpdag EUVIMED
ÜbersichtsarbeitOpen access · CC BY-NC-ND 4.0

Adipose tissue as a therapeutic target for vascular damage in Alzheimer's disease

Miriam Bettinetti-Luque iD, Laura Trujillo-Estrada iD, Eduardo Garcia-Fuentes iD, Juana Andreo-Lopez iD, Raquel Sanchez-Varo iD, Lourdes Garrido-Sánchez iD, Ángela Gómez-Mediavilla iD, Manuela G López iD, Melissa Garcia-Caballero iD, Antonia Gutierrez iD, David Baglietto-Vargas iD

British Journal of Pharmacology · 2024

DOI: 10.1111/bph.16243 ↗

At a glance

Übersichtsarbeit in British Journal of Pharmacology, 2024. Written by Miriam Bettinetti-Luque and 10 co-authors. Institution: Departamento de Biología Celular, Genética y Fisiología, Instituto de Investigación Biomédica de Málaga (IBIMA)-Plataforma BIONAND, Facultad de Cienc…. Major MEDLINE topics: Alzheimer Disease. Cited 18 times so far (Crossref); 451 references. The full text is freely available (open access, CC BY-NC-ND 4.0). Funded by: Alzheimer's Association, Ministerio de Ciencia e Innovación, Instituto de Salud Carlos III.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Adipose tissue has recently been recognized as an important endocrine organ that plays a crucial role in energy metabolism and in the immune response in many metabolic tissues. With this regard, emerging evidence indicates that an important crosstalk exists between the adipose tissue and the brain. However, the contribution of adipose tissue to the development of age‐related diseases, including Alzheimer's disease, remains poorly defined. New studies suggest that the adipose tissue modulates brain function through a range of endogenous biologically active factors known as adipokines, which can cross the blood–brain barrier to reach the target areas in the brain or to regulate the function of the blood–brain barrier. In this review, we discuss the effects of several adipokines on the physiology of the blood–brain barrier, their contribution to the development of Alzheimer's disease and their therapeutic potential. LINKED ARTICLES This article is part of a themed issue From Alzheimer's Disease to Vascular Dementia: Different Roads Leading to Cognitive Decline. To view the other articles in this section visit http://onlinelibrary.wiley.com/doi/10.1111/bph.v181.6/issuetoc

Subjects

MeSH terms (MEDLINE)

Alzheimer DiseaseHumansAdipokinesBrainAdipose TissueBlood-Brain Barrier

Author keywords

Alzheimer's diseaseadipokinesadipose tissueamyloidinflammationtauvascular

Substances

Adipokines

Authors and institutions

  • Departamento de Biología Celular, Genética y Fisiología, Instituto de Investigación Biomédica de Málaga (IBIMA)-Plataforma BIONAND, Facultad de Ciencias, Universidad de Málaga, Málaga, Spain.
  • CIBER de Enfermedades Neurodegenerativas (CIBERNED), Instituto de Salud Carlos III, Madrid, Spain.
  • Unidad de Gestión Clínica Aparato Digestivo, Hospital Universitario Virgen de la Victoria, Instituto de Investigación Biomédica de Málaga (IBIMA)-Plataforma BIONAND, Málaga, Spain.
  • CIBER de Enfermedades Hepáticas y Digestivas (CIBEREHD), Instituto de Salud Carlos III, Madrid, Spain.
  • Departamento de Fisiología Humana, Histología Humana, Anatomía Patológica y Educación Física y Deportiva, Facultad de Medicina, Universidad de Málaga, Málaga, Spain.
  • CIBER de Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III, Madrid, Spain.

ORCID profiles: Miriam Bettinetti-Luque, Laura Trujillo-Estrada, Eduardo Garcia-Fuentes, Juana Andreo-Lopez, Raquel Sanchez-Varo, Lourdes Garrido-Sánchez, Ángela Gómez-Mediavilla, Manuela G López, Melissa Garcia-Caballero, Antonia Gutierrez, David Baglietto-Vargas

Funding

  • Alzheimer's Association
  • Ministerio de Ciencia e Innovación
  • Instituto de Salud Carlos III

Cite

APA

Bettinetti-Luque, M., Trujillo-Estrada, L., Garcia-Fuentes, E., Andreo-Lopez, J., Sanchez-Varo, R., Garrido-Sánchez, L., Gómez-Mediavilla, Á., López, M. G., Garcia-Caballero, M., Gutierrez, A., & Baglietto-Vargas, D. (2024). Adipose tissue as a therapeutic target for vascular damage in Alzheimer's disease. British Journal of Pharmacology. https://doi.org/10.1111/bph.16243

Vancouver

Bettinetti-Luque M, Trujillo-Estrada L, Garcia-Fuentes E, Andreo-Lopez J, Sanchez-Varo R, Garrido-Sánchez L, et al. Adipose tissue as a therapeutic target for vascular damage in Alzheimer's disease. British Journal of Pharmacology. 2024. doi:10.1111/bph.16243

BibTeX
@article{BettinettiLuque2024,
  author = {Bettinetti-Luque, Miriam and Trujillo-Estrada, Laura and Garcia-Fuentes, Eduardo and Andreo-Lopez, Juana and Sanchez-Varo, Raquel and Garrido-Sánchez, Lourdes and Gómez-Mediavilla, Ángela and López, Manuela G and Garcia-Caballero, Melissa and Gutierrez, Antonia and Baglietto-Vargas, David},
  title = {Adipose tissue as a therapeutic target for vascular damage in Alzheimer's disease},
  journal = {British Journal of Pharmacology},
  year = {2024},
  doi = {10.1111/bph.16243}
}
Start for free →